Osigraft 3.3mg powder for implantation suspension vials
Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Eptotermin alfa
Available from:
Olympus Biotech UK Ltd
INN (International Name):
Eptotermin alfa
Dosage:
3.3mg
Pharmaceutical form:
Implantation suspension
Administration route:
Intraosseous
Class:
No Controlled Drug Status
Prescription type:
Valid as a prescribable product
Product summary:
BNF:
